藥_產品搜索_第167頁_醫(yī)化信息網

當前位置: 首頁 » 產品 » 搜索

Medetomidine
Medetomidine(Domtor) is a potent, highly selective 2-adrenoceptor agonist (Ki values are 1.08 and 1750 nM for 2- and 1-a
2016-02-01 16:59 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

558.00/5mg
05mg起訂

Rimonabant (Hydrochloride)
Rimonabant Hcl(SR141716A) is a selective central cannabinoid (CB1) receptor inverse agonist with Ki of 1.8 nM.IC50 Value
2016-02-01 16:55 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

976.00/50mg
050mg起訂

Rimonabant
Rimonabant(SR141716) is a selective central cannabinoid (CB1) receptor inverse agonist with Ki of 1.8 nM.IC50 Value: 1.8
2016-02-01 16:54 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3000.00/100mg
0100mg起訂

Trimebutine (maleate)
Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects.Target: Opioid ReceptorTrimebutine
2016-02-01 16:52 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

500.00/5g
05g起訂

Dipraglurant
Dipraglurant (ADX 48621) is a mGluR5 antagonists with IC50 of 0.021 M.公司介紹：MedChemExpress(MCE)專注于各種抑制劑、激
2016-02-01 16:51 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3190.00/5mg
05mg起訂

Salirasib
Salirasib(S-Farnesylthiosalicylic aci) is an S-farnesyl cysteine analog that interferes with docking of active GTP-bound
2016-02-01 16:49 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2604.00/100mg
0100mg起訂

Brexpiprazole
Brexpiprazole is a novel D2 dopamine partial agonist.IC50 Value: N/ATarget: Dopamine Receptorin vitro: Brexpiprazole (OP
2016-02-01 16:46 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

13950.00/50mg
050mg起訂

Clopidogrel
Clopidogrel is a well-known P2Y12 receptor blocker.IC50 value:Target: P2Y12 receptorClopidogrel (INN) is an oral, thieno
2016-02-01 16:44 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1450.00/1G
01G起訂

Tegaserod (maleate)
Tegaserod maleate is a partial agonist of the 5-HT4 receptor; stimulates the peristaltic reflex and accelerates gastroin
2016-02-01 16:42 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

920.00/10mg
010mg起訂

Fimasartan
Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and hear
2016-02-01 16:41 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1400.00/5mg
05mg起訂

BAN ORL 24
BAN ORL 24 is a potent and selective NOP receptor antagonist.公司介紹：MedChemExpress(MCE)專注于各種抑制劑、激動劑、API
2016-02-01 16:39 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1116.00/10mg
010mg起訂

K-Ras G12C-IN-3
K-Ras G12C-IN-3 is a novel and irreversible inhibitor of mutant K-ras G12C.IC50 value:Target: K-ras G12C inhibitorFor mo
2016-02-01 16:38 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3500.00/5mg
05mg起訂

K-Ras G12C-IN-2
K-Ras G12C-IN-2 is a novel and irreversible inhibitor of mutant K-ras G12C.IC50 value:Target: K-ras G12C inhibitorFor mo
2016-02-01 16:36 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

21000.00/100mg
0100mg起訂

K-Ras G12C-IN-1
K-Ras G12C-IN-1 is a novel and irreversible inhibitor of mutant K-ras G12C.IC50 value:Target: K-ras G12C inhibitorFor mo
2016-02-01 16:34 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3500.00/5mg
05mg起訂

Promethazine (hydrochloride)
Promethazine Hcl(NSC-231688) is the first-generation antihistamine; strong antagonist of the H1 receptor and moderate mA
2016-02-01 16:33 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

500.00/1g
01g起訂

Olmesartan (medoxomil)
Olmesartan medoxomil(Olmetec; Benicar; CS 866) is an angiotensin II receptor antagonist which is used as an anti-hyperte
2016-02-01 16:31 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

810.00/10mg
010mg起訂

SCH 527123
SCH-527123 is a potent antagonist of both CXCR1 and CXCR2 with IC50 of 42 nM and 3 nM, respectively.IC50 value: 42 nM (C
2016-02-01 16:29 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2455.00/5mg
05mg起訂

BQ-788
BQ-788 is a potent and selective endothelin receptor subtype B (ETB) antagonist with IC50 of 1.2 nM(inhibits 125I-labele
2016-02-01 16:28 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

5000.00/10mg
010mg起訂

Palonosetron (Hydrochloride)
Palonosetron Hcl is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting
2016-02-01 16:27 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

698.00/100mg
0100mg起訂

Olmesartan
Olmesartan(RNH 6270; CS 088) is an angiotensin II receptor antagonist used to treat high blood pressure.IC50 value:Targe
2016-02-01 16:25 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]